Juvenile Idiopathic Arthritis
📧 Sign up to get email alerts when something new happens for Juvenile Idiopathic Arthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-05-12FDA Approved: TYENNE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for TYENNE (tocilizumab-azg) from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: 30-Second Sit-to-Stand Test for Assessing Functional Capacity in Juvenile Idiopathic Arthritis
Completed clinical trial evaluating the 30-second sit-to-stand test as a measure of functional capacity in Juvenile Idiopathic Arthritis.
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: Reliability and Validity of the Glittre Activities of Daily Living Test in Children and Adolescents With Juvenile Idiopathic Arthritis
This clinical trial assesses the reliability and validity of the Glittre Activities of Daily Living Test in children and adolescents with ju…
-
FDA approval · 2025-04-07FDA Approved: ADALIMUMAB — Supplemental Application (CELLTRION USA, Inc.)
FDA approved a supplemental application for ADALIMUMAB-AATY, a biosimilar adalimumab from Celltrion USA, Inc., in connection with its regula…
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: Adalimumab in JIA-associated Uveitis Stopping Trial [Phase 4]
Phase 4 trial of adalimumab for Juvenile Idiopathic Arthritis-associated uveitis has completed and posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: Articular Damage in Patients With Juvenile Idiopathic Arthritis After Transition to Adult Care
This clinical trial update outlines a planned study to assess articular damage in juvenile idiopathic arthritis patients after transition fr…
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial [Phase 4]
This document notes the MOVE-JIA trial (Phase 4) at Oslo University Hospital pursuing optimization of treatment for Juvenile Idiopathic Arth…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases [Phase 1, Phase 2]
Ongoing Phase 1/Phase 2 clinical trial updates describe infusion of mesenchymal stem cells in multiple autoimmune diseases and indicate the …
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic Arthritis [NA]
Clinical trial evaluating the efficacy and tolerability of an exclusion diet in children with Juvenile Idiopathic Arthritis; currently recru…
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: Sleep Innovations for Preschoolers With Arthritis (SIPA): Developing and Pilot Testing of a Self-Management Intervention [NA]
Results have been posted for the SIPA trial, which developed and pilot-tested a self-management sleep intervention for preschoolers with Juv…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: Core Stabilization Training in Juvenile Spondyloarthropathy [NA]
The trial is evaluating core stabilization training as a non-drug intervention for juvenile spondyloarthritis and is currently recruiting. I…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-mediated Inflammatory Pathology. Observational Multicenter Study.
An observational multicenter study sponsored by Meyer Children's Hospital IRCCS is recruiting to examine eating habits and their association…
-
EMA approval · 2025-03-03EMA Authorised: Nepexto (etanercept) — Biosimilar Collaborations Ireland Limited
EMA authorised Nepexto, a biosimilar of etanercept, developed by Biosimilar Collaborations Ireland Limited, for several inflammatory arthrit…
-
FDA approval · 2025-02-21FDA Approved: XELJANZ XR — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XELJANZ XR (tofacitinib) submitted by Pfizer, updating the extended-release formulation's label.
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Strategies Towards Personalised Treatment in Juvenile Idiopathic Arthritis (JIA). [Phase 4]
Phase 4 clinical trial investigating strategies toward personalized treatment in Juvenile Idiopathic Arthritis has completed.
-
FDA approval · 2025-02-15FDA Approved: NAPROXEN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Naproxen (ANDA074190) from Hikma Pharmaceuticals USA Inc., resulting in an updated approval of t…
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: Self-Management Supported Telerehabilitation in Children and Adolescents With Juvenile Idiopathic Arthritis [NA]
A completed clinical trial investigated self-management supported telerehabilitation for children and adolescents with Juvenile Idiopathic A…
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: Juvenile Idiopathic Arthritis (JIA) Registry
AbbVie-sponsored Juvenile Idiopathic Arthritis (JIA) registry has completed.
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: Prospective Observational Study to Evaluate Secukinumab Treatment Effectiveness in Pediatric Patients With Active Juvenile Enthesitis-related or Psoriatic Arthritis
A prospective observational study to evaluate the effectiveness of secukinumab in pediatric patients with active enthesitis-related arthriti…
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases [Phase 4]
Phase 4 clinical trial is currently enrolling by invitation to evaluate herpes zoster vaccination in patients with inflammatory rheumatic di…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Sleep Shared-Management Intervention for Children With Juvenile Idiopathic Arthritis [NA]
A completed clinical study evaluating a sleep shared-management intervention for children with Juvenile Idiopathic Arthritis has posted resu…
-
FDA approval · 2024-12-19FDA Approved: CELECOXIB — Supplemental Application (Aurobindo Pharma Limited)
FDA supplemental approval for Aurobindo Pharma Limited's generic celecoxib.
-
FDA approval · 2024-12-18FDA Approved: IDACIO — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for IDACIO (adalimumab-aacf) from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: Virtual Self-Management Program for JIA [NA]
A clinical trial is investigating a virtual self-management program for Juvenile Idiopathic Arthritis and is currently recruiting at the Uni…
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Gait Profile and Variables in Pediatric Rheumatic Disease Using a Smart Insole System
A registry-style update on a pediatric gait study using a smart insole to evaluate rheumatic diseases, focusing on juvenile idiopathic arthr…